Polaris Venture Management Co. V »

Lyra Therapeutics shares owned by Polaris Venture Management Co. V

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Polaris Venture Management Co. V from 13F filings

Historical chart of Polaris Venture Management Co. V investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Polaris Venture Management Co. V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Polaris Venture Management Co. V

Quarter filed Position value Share count Share price at filing
2021-09-30 $10M 1.1M 9.12
2021-06-30 $8.8M 1.1M 8.03
2021-03-31 $13M 1.1M 11.59
2020-12-31 $13M 1.1M 11.40
2020-09-30 $12M 1.1M 11.18
2020-06-30 $13M 1.1M 11.34

More positions owned by Polaris Venture Management Co. V

Lyra Therapeutics Common Stock (LYRA)
x4 Pharmaceuticals Common Stock (XFOR)
Atyr Pharma Common Stock
Dare Bioscience Common Stock
Genocea Biosciences Common Stock (GNCAQ)
Pulmatrix Common Stock

View all positions for Polaris Venture Management Co. V

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
BlackRock
BlackRock
Samsara BioCapital
Vanguard Group
Ikarian Capital
Sei Investments
Morgan Stanley
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Everhart Financial Group
Northern Trust

View all funds holding Lyra Therapeutics